Inhibitor | Ki | Ki ratio | ||||||
---|---|---|---|---|---|---|---|---|
CYP2D6.1 | CYP2D6.10 | CYP2D6.17 | 2D6.10/2D6.1 | 2D6.17/2D6.1 | ||||
μM | ||||||||
Dextromethorphan O-demethylation | ||||||||
Cocaine | 1.15 ± 0.14 | 1.74 ± 0.25 | 9.29 ± 1.13 | 1.51 | 8.08 | |||
(S)-Fluoxetine | 1.27 ± 0.12 | 0.40 ± 0.05 | 1.73 ± 0.20 | 0.32 | 1.36 | |||
(S)-Norfluoxetine | 0.84 ± 0.14 | 0.34 ± 0.05 | 1.84 ± 0.31 | 0.41 | 2.19 | |||
Imipramine | 3.34 ± 0.28 | 3.70 ± 0.43 | 11.1 ± 0.8 | 1.11 | 3.32 | |||
Quinidine | 0.011 ± 0.001 | 0.051 ± 0.003 | 0.079 ± 0.005 | 4.64 | 7.18 | |||
Thioridazine | 0.018 ± 0.003 | 0.213 ± 0.017 | 0.166 ± 0.016 | 11.8 | 9.22 | |||
Atomoxetine 4-hydroxylation | ||||||||
Cocaine | 0.35 ± 0.04 | 0.43 ± 0.06 | 1.60 ± 0.21 | 1.23 | 4.57 | |||
(S)-Fluoxetine | 0.67 ± 0.07 | 0.49 ± 0.09 | 0.82 ± 0.09 | 0.73 | 1.22 | |||
(S)-Norfluoxetine | 1.04 ± 0.11 | 0.59 ± 0.11 | 1.16 ± 0.13 | 0.57 | 1.12 | |||
Imipramine | 3.04 ± 0.34 | 4.26 ± 0.43 | 7.64 ± 0.64 | 1.40 | 2.51 | |||
Quinidine | 0.010 ± 0.001 | 0.023 ± 0.002 | 0.056 ± 0.007 | 2.30 | 5.60 | |||
Thioridazine | 0.026 ± 0.002 | 0.494 ± 0.090 | 0.103 ± 0.009 | 19.0 | 3.96 |